imetelstat
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
June, 2024
June 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« May
imetelstat
Jun 11, 2024, 03:04 |
Blog
Vijendra Singh: Why I'm skeptical about Imetelstat's use for MDS treatment
Vijendra Singh, Medical oncologist at Karmanos cancer center, shared a post on X/Twitter: ''Why I'm…
Jun 7, 2024, 13:38 |
Blog
Anand Patel: Imetelstat approved for lower-risk MDS with anemia
Anand Patel, Assistant Professor and Director of the Inpatient Leukemia Service at the University of Chicago,…
Jun 7, 2024, 12:04 |
Drugs
Rami Komrokji: Imetelstat approved for MDS patients
Rami Komrokji, Vice Chair of the Malignant Hematology Department at Moffitt Cancer Center, shared a…
May 20, 2024, 14:02 |
Blog
Talha Badar: Rx of Lower risk MDS, non del 5q, failing ESA/luspatercept
Talha Badar, Assistant Professor at Mayo Clinic Comprehensive Cancer Center shared a thread on X:…
May 8, 2024, 01:20 |
Drugs
Talha Badar: Myelofibrosis after failure of Ruxolitinib
Talha Badar, Assistant Professor at Mayo Clinic Comprehensive Cancer Center shared a thread on Twitter/X:…
Mar 16, 2024, 15:53 |
Drugs
Blood Cancer Expert Dr. Mikkael Sekeres Endorses FDA Approval of New Drug, Imetelstat
Dr. Mikkael Sekeres is an expert in blood cancers at Sylvester Comprehensive Cancer Center - University of…
All:
6
Posts:
1 - 10
New Paper Alert! Long-Term Benefits of Dabrafenib-Trametinib in Stage III Melanoma: 8-Year COMBI-AD Trial Results
We mourn the loss of our Ivy Elkins
FDA grants accelerated approval to adagrasib with cetuximab for KRAS G12C-mutated colorectal cancer
Rob Winn: Honored to receive the ASCO Allen Lichter Visionary Leader Award
Yardena Samuels: An absolute honor to be elected as the next EACR president
Facebook
RSS Feed
Twitter
Linkedin
Youtube